Australia's largest stock trading and investment forum Australia's #1 stock forum

RAC

Click for more information

6.80%

$1.89 race oncology ltd

thanks for the clarification. Had to cut n paste as HC wasn’t...

First 28 Last

Share
Profile

Follow
Boffin99

2,650 Posts.

2768

01/06/24

08:07

Post #: 74114748
Share

Originally posted by Davisite: ↑

No need to use such a large font to get my attention

VO2Peak is the FDA gold standard in cardiology. If we were developing bisantrene as a cardioprotective drug we would go to the FDA cardiac division and say we wanted to use VO2Peak and they would say excellent.

What was picked up by the shareholder was how much effect anthracyclines have on VO2Peak. This is something very new in oncology and not known by oncologists. You can detect the change in LVEF by other techniques like cardiac MRI or 3D echo, but the clinical significance of these changes is unknown - the great thing about VO2Peak is the changes are considered clinically significant even when small and the changes caused by anthracyclines are not small.

I would add that using VO2Peak as an endpoint in an oncology trial greatly increases the chances that we would get breakthrough designation and accelerated approval. Any FDA IND will have to be a cross-divisional application with involvement of both the oncology and cardiology divisions. This is exactly what real breakthrough drugs provide.

Expand

thanks for the clarification. Had to cut n paste as HC wasn’t working. Next time ii will use CAPITALS just to make sure ; )

RAC Price at posting: $1.48 Sentiment: Buy Disclosure: Held
13 Upvote

0 Great analysis

Reply

Top Stories

TLX

Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug

RNU

Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some

I88

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

AUG

Augustus sees imperial share rise on high-grade Cu and gold results at Ti-Tree

TX3

Canadian fieldwork yields multiple pegmatites for Trinex

There are more pages in this discussion • 8 more messages in this thread...

First 28 Last

Add RAC (ASX) to my watchlist

(20min delay)
Last $1.89		Change 0.120(6.80%)		Mkt cap ! $321.0M

Open	High	Low	Value	Volume
$1.78	$1.93	$1.78	$563.4K	302.3K

Buyers (Bids)

No.	Vol.	Price($)
1	108	$1.88

Sellers (Offers)

Price($)	Vol.	No.
$1.90	4926	1

View Market Depth

No.	Vol.	Price($)
1	108	1.880
2	8000	1.855
4	12250	1.850
2	32500	1.840
1	2500	1.835

Price($)	Vol.	No.
1.900	4926	1
1.920	2311	1
1.930	275	1
1.935	10400	1
1.940	5260	1

Last trade - 16.10pm 11/07/2024 (20 minute delay)

RAC (ASX) Chart